NEX Group

Reduced energy use and elevated production to result from fully integrated machine learning, artificial intelligence, and IIoT platform

Retrieved on: 
Monday, October 9, 2023

BRUSSELS, Oct. 9, 2023 /PRNewswire/ -- Rockwell Automation, Inc. (NYSE: ROK), the world's largest company dedicated to industrial automation and digital transformation, today announced that NEXE d.d. is introducing changes in its production processes through digitalization that will offer additional value on the company's path towards further reductions in its carbon footprint.

Key Points: 
  • BRUSSELS, Oct. 9, 2023 /PRNewswire/ -- Rockwell Automation, Inc. (NYSE: ROK), the world's largest company dedicated to industrial automation and digital transformation, today announced that NEXE d.d.
  • is introducing changes in its production processes through digitalization that will offer additional value on the company's path towards further reductions in its carbon footprint.
  • The NEXE Group is well-known within building materials sector in Croatia and the region, specializing in cement, concrete, aggregates, concrete elements, roof tiles and bricks.
  • Danijel Koren, plant manager at NEXE d.d, said: "This is a push forward on this important journey for the whole Group.

If you had any interest in Swiss Franc LIBOR-Based Derivatives during the period of January 1, 2001 through December 31, 2011, your rights may be affected by pending class action settlements, and you may be entitled to a portion of the settlement fund

Retrieved on: 
Friday, June 16, 2023

"Swiss Franc LIBOR-Based Derivatives" means: (i) a three-month Euro Swiss franc futures contract on the London International Financial Futures and Options Exchange ("LIFFE") entered into by a U.S.

Key Points: 
  • "Swiss Franc LIBOR-Based Derivatives" means: (i) a three-month Euro Swiss franc futures contract on the London International Financial Futures and Options Exchange ("LIFFE") entered into by a U.S.
  • Person, or by a Person from or through a location within the U.S.; (v) a Swiss franc currency forward agreement entered into by a U.S.
  • Person, or by a Person from or through a location within the U.S.
    "Swiss franc LIBOR" means the London Interbank Offered Rate for the Swiss franc.
  • For more information, call toll-free 1-855-914-4639 (if calling from outside the United States or Canada, call 1-503-994-1396) or visit www.swissfrancliborclassactionsettlement.com .

Islamic Coin and DDCAP Group™ Announce Significant Partnership for the Global Islamic Market

Retrieved on: 
Wednesday, April 26, 2023

The proposed alliance will focus on building industry grade systems and cater to growing market demand for ethics-first, Shariah compliant infrastructure.

Key Points: 
  • The proposed alliance will focus on building industry grade systems and cater to growing market demand for ethics-first, Shariah compliant infrastructure.
  • DDCAP was most recently recognised at the 2022 Global Islamic Finance Awards for its Market Leadership (Institution) with ETHOS AFP™ awarded Best Islamic Finance Technology Product.
  • DDCAP is a member of the UK Islamic Finance Council (UKIFC) SDG Global Taskforce, formed under the auspices of HM Treasury in the UK.
  • The partnership introduced DDCAP as a founder member of the higher-level working group tasked to promote the acceleration of Green and Sustainable Sukuk.

KCAS Bioanalytical and Biomarker Services Announces Growth to Scientific Leadership Team

Retrieved on: 
Tuesday, April 25, 2023

In addition, he will continue his role as a key member of our current operations integration team and the Senior Leadership Team.

Key Points: 
  • In addition, he will continue his role as a key member of our current operations integration team and the Senior Leadership Team.
  • “I look forward to this new opportunity to expand further the footprint of the bioanalytical and Biomarkers fields at KCAS.
  • As Executive Director, Cheikh will be responsible for the strategic leadership and management oversight of our Biopharma Services division, positioning the company for continued growth.
  • In addition, he will be an integral member of our global Integration strategy and will continue to be a member of the Senior Leadership Team.

Flagship Biosciences hires Tom Turi, Ph.D., as new Chief Scientific Officer

Retrieved on: 
Tuesday, September 27, 2022

BROOMFIELD, Colo., Sept. 27, 2022 /PRNewswire/ -- Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the hiring of Tom Turi, Ph.D., as their new Chief Scientific Officer. Tom is an accomplished leader in the pharmaceutical industry having championed strategic and tactical business development plans in disciplines such as companion diagnostics (CDx), biomarker discovery, functional genomics, and computational biology. His expertise will help guide the integration and implementation of new genomic and bioinformatic capabilities obtained through Flagship Biosciences' recent acquisition of Interpace Pharma Solutions®.

Key Points: 
  • BROOMFIELD, Colo., Sept. 27, 2022 /PRNewswire/ -- Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the hiring of Tom Turi, Ph.D. , as their new Chief Scientific Officer.
  • His expertise will help guide the integration and implementation of new genomic and bioinformatic capabilities obtained through Flagship Biosciences' recent acquisition of Interpace Pharma Solutions .
  • He will be essential in driving our scientific strategy along with growing our scientific leadership and expertise," said Trevor Johnson, CEO at Flagship Biosciences.
  • From 2020-2022, Tom served as Chief Scientific Officer at Nexelis where he led the overall scientific direction of the company.

ProtaGene Names Pharmaceutical Industry Leader Raymond Kaiser as Chief Executive Officer to Drive Next Stages of Growth

Retrieved on: 
Wednesday, September 21, 2022

Ray will drive the continued innovation and growth strategy for the company's advanced analytical services.

Key Points: 
  • Ray will drive the continued innovation and growth strategy for the company's advanced analytical services.
  • Ray first joined ProtaGene earlier this year as Chief Operating Officer.
  • "ProtaGene is incredibly well-positioned to serve as an analytical leader that supports the development of diverse therapeutic modalities," commented Blggel.
  • Before joining ProtaGene, Ray was the Chief Operating Officer at Nexelis, overseeing operations, business strategy, and enhanced service offerings for pre-clinical and clinical bioanalytical testing.

ProtaGene Names Pharmaceutical Industry Leader Raymond Kaiser as Chief Executive Officer to Drive Next Stages of Growth

Retrieved on: 
Wednesday, September 21, 2022

Ray will drive the continued innovation and growth strategy for the company's advanced analytical services.

Key Points: 
  • Ray will drive the continued innovation and growth strategy for the company's advanced analytical services.
  • Ray first joined ProtaGene earlier this year as Chief Operating Officer.
  • "ProtaGene is incredibly well-positioned to serve as an analytical leader that supports the development of diverse therapeutic modalities," commented Blggel.
  • Before joining ProtaGene, Ray was the Chief Operating Officer at Nexelis, overseeing operations, business strategy, and enhanced service offerings for pre-clinical and clinical bioanalytical testing.

CME Group Announces New Regional Leadership Structure to Strengthen Focus on International Business Growth and Facilitate Enhanced Service to Clients Outside the United States

Retrieved on: 
Tuesday, April 12, 2022

Everaert joined CME Group in 2011 and most recently served as the company's Managing Director and Co-Head of Client Development & Sales (CD&S) for EMEA.

Key Points: 
  • Everaert joined CME Group in 2011 and most recently served as the company's Managing Director and Co-Head of Client Development & Sales (CD&S) for EMEA.
  • He has 30 years of experience in derivatives markets including roles at IMEX Group, GFI Group, Logica, Reuters and Dow Jones.
  • Russell Beattie will join CME Group in May as Managing Director and Head of Asia Pacific.
  • In Q1 2022, outside the United States, CME Group reached average daily volume (ADV) of 7.3 million contracts, up 18% year on year.

Bittrex Global Names Paul Grier as Chief Marketing Officer

Retrieved on: 
Monday, January 10, 2022

Bittrex Global, the leading digital asset exchange, announced today the appointment of Paul Grier as Chief Marketing Officer for the company.

Key Points: 
  • Bittrex Global, the leading digital asset exchange, announced today the appointment of Paul Grier as Chief Marketing Officer for the company.
  • Paul is a seasoned marketing leader bringing a wealth of experience to his role at Bittrex Global, says Stephen Stonberg, CEO of Bittrex Global.
  • In his new role at Bittrex Global, Mr. Grier will oversee internal and external marketing directives, spearhead activities related to growing brand awareness and expansion, and will be responsible for managing Bittrex Globals extensive client communication portfolio.
  • I am very excited to join Bittrex Global and help the company continue to blaze a trail as a leader and visionary in the digital asset exchange space, said Paul Grier.

CME Group to Launch Two China Portside Iron Ore Futures Contracts on January 10

Retrieved on: 
Thursday, December 9, 2021

SINGAPORE, Dec. 9, 2021 /PRNewswire/ -- CME Group ,the world's leading and most diverse derivatives marketplace, today announced that it will launch two new China portside iron ore futures contracts on January 10, 2022, pending all relevant regulatory reviews.

Key Points: 
  • SINGAPORE, Dec. 9, 2021 /PRNewswire/ -- CME Group ,the world's leading and most diverse derivatives marketplace, today announced that it will launch two new China portside iron ore futures contracts on January 10, 2022, pending all relevant regulatory reviews.
  • The Iron Ore China Portside Fines CNH fot Qingdao (Argus) futures contract will settle to the Argus PCX 62% Fe Portside Iron Ore Index and is quoted in CNH per wet metric ton, while the Iron Ore China Portside Fines USD Seaborne Equivalent (Argus) futures contract will settle to the Argus PCX Seaborne equivalent index and is quoted in USD per dry metric ton.
  • "Argus prices have rapidly gained traction in the physical iron ore market, and we are delighted that Argus' China portside iron ore indexes have been chosen as the settlement basis for the new CME futures contracts," said Adrian Binks, Chairman and Chief Executive of Argus Media.
  • The China portside iron ore futures contracts will be listed by and subject to the rules of COMEX.